Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin + tadalafil versus tadalafil for lower urinary tract symptoms due to benign prostatic hyperplasia
KCT0004492Phase 4Terminated
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terazosin, tadalafil in benign prostatic hyperplasia (BPH), erectile dysfunction (ED), sponsored by Il-Yang Pharmaceutical. Started Dec 2019; status: terminated.
02
Drugs
terazosintadalafil
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on KCT0004492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004492.